About Koligo Therapeutics
Koligo Therapeutics is a company based in Louisville (United States) founded in 2016 was acquired by Orgenesis in September 2020.. Koligo Therapeutics has raised $3.65 million across 2 funding rounds from investors including Orgenesis. Koligo Therapeutics operates in a competitive market with competitors including Neurocrine, Crinetics, Sana Biotechnology, Semma Therapeutics and Adocia, among others.
- Headquarter Louisville, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Koligo Therapeutics
Koligo Therapeutics has successfully raised a total of $3.65M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.65 million completed in October 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $1.6M
-
First Round
First Round
(06 Mar 2018)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2020 | Amount | Seed - Koligo Therapeutics | Valuation |
investors |
|
| Mar, 2018 | Amount | Seed - Koligo Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Koligo Therapeutics
Koligo Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Orgenesis. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cell and gene therapies for multiple disorders are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Koligo Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Koligo Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Koligo Therapeutics Comparisons
Competitors of Koligo Therapeutics
Koligo Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neurocrine, Crinetics, Sana Biotechnology, Semma Therapeutics and Adocia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| domain | founded_year | HQ Location |
Developer of therapies for the treatment of endocrine-related diseases and cancers
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
|
|
| domain | founded_year | HQ Location |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for metabolic and orphan diseases are developed by Rezolute.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Koligo Therapeutics
Frequently Asked Questions about Koligo Therapeutics
When was Koligo Therapeutics founded?
Koligo Therapeutics was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Where is Koligo Therapeutics located?
Koligo Therapeutics is headquartered in Louisville, United States. It is registered at Louisville, Kentucky, United States.
Is Koligo Therapeutics a funded company?
Koligo Therapeutics is a funded company, having raised a total of $3.65M across 2 funding rounds to date. The company's 1st funding round was a Seed of $2M, raised on Mar 06, 2018.
What does Koligo Therapeutics do?
Koligo Therapeutics is developing trans-formative cell therapies for treating chronic pancreatitis and Type I diabetes. Their lead candidate, Kyslecel (infused into the liver), which is made from autologous pancreatic islets. The candidate has complete clinical studies and ready to be marketed. It is used for treating chronic pancreatitis.
Who are the top competitors of Koligo Therapeutics?
Koligo Therapeutics's top competitors include Crinetics, Neurocrine and Sana Biotechnology.
Who are Koligo Therapeutics's investors?
Koligo Therapeutics has 1 investor. Key investors include Orgenesis.